Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin

NCT00354796 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00354796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2006
Completion date
October 31, 2015
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, atrial fibrillation, hypercoagulability, venous thromboembolism